Biogen Pharmachem Industries Other Announcement
Biogen Pharmachem Industries submitted its quarterly certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The registrar confirmed that no physical share certificates were received for dematerialization during the quarter. This is a routine compliance filing with no material impact on business operations.